<h4>Neurology</h4>
<table class="table table-bordered">
	<thead>
	<tr>
		<th width="10%">CODE</th>
		<th width="70%">TEST</th>
		<th width="10%">METHOD</th>
		<th width="10%">TAT</th>
	</tr>
	</thead>
	<tbody>
	<tr>
		<td align="left">MGM229</td>
		<td align="left"><em>TSC1</em> &amp; <em>TSC2</em> gene analysis</td>
		<td align="left">NGS</td>
		<td align="left">4 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM230</td>
		<td align="left"><em>TSC1</em> &amp; <em>TSC2</em> gene analysis</td>
		<td align="left">Sanger</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM231</td>
		<td align="left"><em>TSC1</em> deletion/duplication analysis</td>
		<td align="left">MLPA</td>
		<td align="left">3 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM232</td>
		<td align="left"><em>TSC1</em> gene analysis</td>
		<td align="left">Sanger</td>
		<td align="left">4 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM233</td>
		<td align="left"><em>TSC2</em> deletion/duplication analysis</td>
		<td align="left">MLPA</td>
		<td align="left">3 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM234</td>
		<td align="left"><em>TSC2</em> gene analysis</td>
		<td align="left">Sanger</td>
		<td align="left">4 WEEKS</td>
	</tr>
	<tr>
		<td colspan="4" align="center"><strong>EPILEPSY</strong></td>
	</tr>
	<tr>
		<td align="left">MGM109</td>
		<td align="left">Benign infantile epilepsy gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM110</td>
		<td align="left">Dravet syndrome gene panel</td>
		<td align="left">NGS</td>
		<td align="left">4 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM111</td>
		<td align="left">Dravet syndrome (<em>SCN1A</em>) deletion/duplication analysis</td>
		<td align="left">MLPA</td>
		<td align="left">3 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM112</td>
		<td align="left">Epileptic encephalopathy gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM113</td>
		<td align="left">Familial female mental retardation/epilepsy gene panel</td>
		<td align="left">NGS</td>
		<td align="left">4 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM114</td>
		<td align="left">Progressive myoclonic epilepsy gene panel</td>
		<td align="left">NGS</td>
		<td align="left">3 WEEKS</td>
	</tr>
	<tr>
		<td colspan="4" align="center"><strong>LEUKODYSTROPHIES</strong></td>
	</tr>
	<tr>
		<td align="left">MGM115</td>
		<td align="left">Adrenoleukodystrophy gene panel</td>
		<td align="left">NGS</td>
		<td align="left">4 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM116</td>
		<td align="left">Canavan disease (<em>ASPA</em>) gene analysis</td>
		<td align="left">NGS</td>
		<td align="left">4 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM117</td>
		<td align="left">Canavan disease (<em>ASPA</em>) deletion/duplication analysis</td>
		<td align="left">MLPA</td>
		<td align="left">3 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM118</td>
		<td align="left">Hypomyelination syndrome gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM119</td>
		<td align="left">Krabbe disease (<em>GALC</em>) gene analysis</td>
		<td align="left">NGS</td>
		<td align="left">4 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM120</td>
		<td align="left">Krabbe disease (<em>GALC</em>) deletion/duplication analysis</td>
		<td align="left">MLPA</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM121</td>
		<td align="left">Leukodystrophy gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM122</td>
		<td align="left">Metachromatic leukodystrophy gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td colspan="4" align="center"><strong>MOVEMENT DISORDERS</strong></td>
	</tr>
	<tr>
		<td align="left">MGM123</td>
		<td align="left">Ataxia-telangiectasia (<em>ATM</em>) deletion/duplication analysis</td>
		<td align="left">MLPA</td>
		<td align="left">3 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM124</td>
		<td align="left">Ataxia-telangiectasia (<em>ATM</em>) gene analysis</td>
		<td align="left">NGS</td>
		<td align="left">4 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM125</td>
		<td align="left">Dystonia gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM126</td>
		<td align="left">Early-onset juvenile parkinsonism gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM127</td>
		<td align="left">Episodic ataxia gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM128</td>
		<td align="left">Hyperekplexia gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM129</td>
		<td align="left">Pantothenate kinase-associated neurodegeneration (<em>PANK2</em>) deletion/duplication analysis</td>
		<td align="left">MLPA</td>
		<td align="left">3 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM130</td>
		<td align="left">Pantothenate kinase-associated neurodegeneration gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td colspan="4" align="center"><strong>NEUROMUSCULAR</strong></td>
	</tr>
	<tr>
		<td align="left">MGM131</td>
		<td align="left">Arthrogryposis &amp; congenital myasthenic syndrome gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM132</td>
		<td align="left">Charcot-Marie-Tooth and sensory neuropathies gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM133</td>
		<td align="left">Charcot-Marie-Tooth and 1A/HNPP (<em>PMP22</em>, <em>COXI0</em>, <em>TEKT3</em>) deletion/duplication analysis</td>
		<td align="left">MLPA</td>
		<td align="left">3 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM134</td>
		<td align="left">Charcot-Marie-Tooth <em>PMP22</em> deletion/duplication analysis</td>
		<td align="left">MLPA</td>
		<td align="left">3 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM135</td>
		<td align="left">Congenital Muscular Dystrophy (<em>LAMA2</em>) deletion/duplication analysis</td>
		<td align="left">MLPA</td>
		<td align="left">3 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM136</td>
		<td align="left">Duchenne Muscular Dystrophy (<em>DMD</em>) deletion/duplication analysis</td>
		<td align="left">MLPA</td>
		<td align="left">3 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM137</td>
		<td align="left">Duchenne Muscular Dystrophy (<em>DMD</em>) gene sequencing</td>
		<td align="left">NGS</td>
		<td align="left">4 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM138</td>
		<td align="left">Dysferlinopathy/LGMD2A (<em>CAPN3</em>) deletion/duplication analysis</td>
		<td align="left">MLPA</td>
		<td align="left">3 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM139</td>
		<td align="left">Dysferlinopathy/LGMD2B (<em>DYSF</em>) deletion/duplication analysis</td>
		<td align="left">MLPA</td>
		<td align="left">3 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM140</td>
		<td align="left">Limb-girdle muscular dystrophy deletion/duplication analysis (<em>SGCA</em>, <em>SGCB</em>, <em>SGCD</em>, <em>SGCG</em> &amp; <em>FKRP</em>)</td>
		<td align="left">MLPA</td>
		<td align="left">3 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM141</td>
		<td align="left">Muscular dystrophy &amp; congenital myopathy gene panel</td>
		<td align="left">NGS</td>
		<td align="left">4 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM142</td>
		<td align="left">Myotonia congenita gene panel</td>
		<td align="left">NGS</td>
		<td align="left">4 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM143</td>
		<td align="left">Spinal Muscular Atrophy (<em>SMN1</em>/<em>SMN2</em>) deletion/duplication analysis</td>
		<td align="left">MLPA</td>
		<td align="left">3 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM144</td>
		<td align="left">Spinal Muscular Atrophy (<em>SMN1</em>) gene analysis</td>
		<td align="left">Sanger</td>
		<td align="left">4 WEEKS</td>
	</tr>
	<tr>
		<td colspan="4" align="center"><strong>OTHERS</strong></td>
	</tr>
	<tr>
		<td align="left">MGM145</td>
		<td align="left">4H syndrome gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM146</td>
		<td align="left">Aicardi-Goutieres syndrome gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM147</td>
		<td align="left">Cockayne syndrome gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM148</td>
		<td align="left">Comprehensive neurology panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM149</td>
		<td align="left">Congenital hydrocephalus gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM150</td>
		<td align="left">Cystic megalencephaly (<em>MLC1</em>) gene analysis</td>
		<td align="left">NGS</td>
		<td align="left">4 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM151</td>
		<td align="left">Familial hemiplegic migraine gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM152</td>
		<td align="left">Hereditary spastic paraplegia gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM153</td>
		<td align="left">Joubert syndrome gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM154</td>
		<td align="left">Lissencephaly gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM155</td>
		<td align="left">Microcephaly gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM156</td>
		<td align="left">Neuronal ceroid lipofuscinosis gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM157</td>
		<td align="left">Neuronal migration disorder gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM158</td>
		<td align="left">NOTCH3 (<em>CADASIL</em>) gene analysis</td>
		<td align="left">NGS</td>
		<td align="left">4 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM159</td>
		<td align="left">NOTCH3 (<em>CADASIL</em>) gene analysis &#8211; 2 exons (2 &amp; 3)</td>
		<td align="left">Sanger</td>
		<td align="left">10 DAYS</td>
	</tr>
	<tr>
		<td align="left">MGM160</td>
		<td align="left">Pontocerebellar hypoplasia gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM161</td>
		<td align="left">Rett Syndrome (<em>MECP2</em>) deletion/duplication analysis</td>
		<td align="left">MLPA</td>
		<td align="left">3 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM162</td>
		<td align="left">Rett Syndrome (<em>MECP2</em>) gene panel</td>
		<td align="left">NGS</td>
		<td align="left">4 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM163</td>
		<td align="left">Tay–Sachs disease (<em>HEXA</em>) deletion/duplication analysis</td>
		<td align="left">MLPA</td>
		<td align="left">3 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM164</td>
		<td align="left">Tay–Sachs disease (<em>HEXA</em>) gene analysis</td>
		<td align="left">NGS</td>
		<td align="left">4 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM165</td>
		<td align="left">X-linked spastic paraplegia-2 (<em>PLP1</em>)<br />
			deletion/duplication analysis</td>
		<td align="left">MLPA</td>
		<td align="left">3 WEEKS</td>
	</tr>
	<tr>
		<td align="left">MGM166</td>
		<td align="left">X-linked mental retardation gene panel</td>
		<td align="left">NGS</td>
		<td align="left">6 WEEKS</td>
	</tr>
	</tbody>
</table>